Literature DB >> 2720300

Variable, voltage-dependent, blocking effects of nitrendipine, verapamil, diltiazem, cinnarizine and cadmium on adrenomedullary secretion.

M G López1, M A Moro, C F Castillo, C R Artalejo, A G García.   

Abstract

1. Catecholamine release from cat adrenal glands perfused at a high rate (4 ml min-1) at 37 degrees C with modified Krebs solutions lacking Ca and containing 1.2 mM K (hyperpolarizing solution) or 118 mM K (depolarizing solution) was triggered by 10-s pulses of Ca (0.5 mM) in the presence of 118 mM K. Hyperpolarized glands released 1280 +/- 135 ng per pulse and depolarized glands 831 +/- 98 ng per pulse (n = 29). 2. While the dihydropyridine Ca channel blocker nitrendipine inhibited secretion in hyperpolarized glands with an IC50 of 214 nM, in depolarizing conditions the drug was much more potent (IC50 = 0.99 nM). In contrast, the inorganic Ca channel blocker cadmium inhibited secretion with the same potency both in hyperpolarized or depolarized glands. 3. Cinnarizine, diltiazem and verapamil exhibited intermediate degrees of voltage-dependence in blocking secretion. The IC50 ratios between hyperpolarized and depolarized glands were 215, 36, 19, 8 and 0.76 respectively for nitrendipine, cinnarizine, diltiazem, verapamil and cadmium. Because the experimental design (strong depolarization in the absence of Ca) favours the highest opening probability of Ca channels, it seems that these drugs bind preferentially to their receptors when these channels are in their open state. 4. Variable voltage-dependent effects of the five Ca channel blockers on adrenomedullary catecholamine release suggests different sites and mechanisms of action on, or near L-type Ca channels in chromaffin cells. In addition, these findings might help to explain why these drugs exhibit tissue selectivity and why they act differently in normal polarized as compared to ischaemic depolarized cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2720300      PMCID: PMC1854390          DOI: 10.1111/j.1476-5381.1989.tb11874.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

1.  Voltage-dependent block of calcium channel current in the calf cardiac Purkinje fiber by dihydropyridine calcium channel antagonists.

Authors:  M C Sanguinetti; R S Kass
Journal:  Circ Res       Date:  1984-09       Impact factor: 17.367

2.  A rapid, simplified procedure for simultaneous assay of norepinephrine, dopamine, and 5-hydroxytryptamine from discrete brain areas.

Authors:  M K Shellenberger; J H Gordon
Journal:  Anal Biochem       Date:  1971-02       Impact factor: 3.365

3.  Different modes of Ca channel gating behaviour favoured by dihydropyridine Ca agonists and antagonists.

Authors:  P Hess; J B Lansman; R W Tsien
Journal:  Nature       Date:  1984 Oct 11-17       Impact factor: 49.962

4.  Pharmacological dissection of receptor-associated and voltage-sensitive ionic channels involved in catecholamine release.

Authors:  V Ceña; G P Nicolas; P Sanchez-Garcia; S M Kirpekar; A G Garcia
Journal:  Neuroscience       Date:  1983-12       Impact factor: 3.590

5.  Diltiazem potentiates the negative inotropic action of nimodipine in heart.

Authors:  A DePover; I L Grupp; G Grupp; A Schwartz
Journal:  Biochem Biophys Res Commun       Date:  1983-08-12       Impact factor: 3.575

6.  Functional interactions of calcium-antagonists in K+-depolarized smooth muscle.

Authors:  M Spedding
Journal:  Br J Pharmacol       Date:  1983-11       Impact factor: 8.739

7.  Voltage-dependence of nitrendipine provides direct evidence for dihydropyridine receptor coupling to calcium channels in intact cat adrenals.

Authors:  C R Artalejo; M G López; M A Moro; C F Castillo; R de Pascual; A G García
Journal:  Biochem Biophys Res Commun       Date:  1988-06-30       Impact factor: 3.575

8.  Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialysed heart cells.

Authors:  K S Lee; R W Tsien
Journal:  Nature       Date:  1983-04-28       Impact factor: 49.962

9.  Dihydropyridine BAY-K-8644 activates chromaffin cell calcium channels.

Authors:  A G García; F Sala; J A Reig; S Viniegra; J Frías; R Fontériz; L Gandía
Journal:  Nature       Date:  1984 May 3-9       Impact factor: 49.962

10.  Effects of the novel dihydropyridine BAY-K-8644 on adrenomedullary catecholamine release evoked by calcium reintroduction.

Authors:  C Montiel; A R Artalejo; A G García
Journal:  Biochem Biophys Res Commun       Date:  1984-05-16       Impact factor: 3.575

View more
  6 in total

1.  Nifedipine blocks Ca2+ store refilling through a pathway not involving L-type Ca2+ channels in rabbit arteriolar smooth muscle.

Authors:  T M Curtis; C N Scholfield
Journal:  J Physiol       Date:  2001-05-01       Impact factor: 5.182

2.  Voltage inactivation of Ca2+ entry and secretion associated with N- and P/Q-type but not L-type Ca2+ channels of bovine chromaffin cells.

Authors:  M Villarroya; R Olivares; A Ruíz; M F Cano-Abad; R de Pascual; R B Lomax; M G López; I Mayorgas; L Gandía; A G García
Journal:  J Physiol       Date:  1999-04-15       Impact factor: 5.182

3.  Inactivation characteristics reveal two calcium currents in adult bovine chromaffin cells.

Authors:  J L Bossu; M De Waard; A Feltz
Journal:  J Physiol       Date:  1991-06       Impact factor: 5.182

4.  Voltage-dependent inactivation of catecholamine secretion evoked by brief calcium pulses in the cat adrenal medulla.

Authors:  B Garrido; M G López; M A Moro; R de Pascual; A G García
Journal:  J Physiol       Date:  1990-09       Impact factor: 5.182

5.  (+)-isradipine but not (-)-Bay-K-8644 exhibits voltage-dependent effects on cat adrenal catecholamine release.

Authors:  M G López; P Michelena; L Gandía; A G García
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

Review 6.  Recent advances in delivery systems and therapeutics of cinnarizine: a poorly water soluble drug with absorption window in stomach.

Authors:  Smita Raghuvanshi; Kamla Pathak
Journal:  J Drug Deliv       Date:  2014-11-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.